SUNNYVALE, Calif., Sept. 2, 2011 /PRNewswire/ — Today,
Molecular Devices, a leading provider of instruments, software, and
consumables for drug discovery and life sciences research,
announced the addition of the TUNE detection cartridge to the
SpectraMax Paradigm Multi-Mode Microplate Detection Platform. The
breakthrough technology of TUNE with wavelength flexibility in a
monochromator device and up to 10x the sensitivity will benefit
both the research and screening markets.
(Logo: http://photos.prnewswire.com/prnh/20100406/SF82092LOGO)
The SpectraMax Paradigm Detection Platform is the only user
upgradeable microplate reader on the market today. It allows the
user to read what they want, when they want. Now, with the TUNE
detection cartridge, the Paradigm system is the most flexible
instrument available. The patent pending Spectral Optimization
Wizard in SoftMax® Pro software reduces the assay set up time
by more than 50% with simultaneous scanning of excitation and
emission spectrums.
Flexibility for Research
For the researchers who need the wavelength flexibility of a
monochromator in fluorescent applications, TUNE will offer
unmatched sensitivity allowing them to test new assays and further
advance their research. The flexibility of the Paradigm platform
and ability to easily add future options, makes it a great
investment for their labs.
Speed of Paradigm with Sensitivity of TUNE, Ideal for
Screening
The TUNE cartridge enables monochromator-like wavelength
flexibility without compromising on sensitivity. The Paradigm
platform is built with on-the-fly detection for reduced read times,
plate format of up to 1536-wells, dual PMTs, and was designed with
automation in mind, all important features for high throughput. Use
of the TUNE cartridge with the Paradigm instrument will meet the
needs of screeners with high sensitivity and
‘/>”/>
SOURCE